XML 25 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows
$ in Thousands
12 Months Ended
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Operating activities:      
Net income $ 16,817 $ 47,384 $ 98,278
Adjustments to reconcile net income to net cash provided by operating activities:      
Loss (income) from discontinued operations, net of income taxes 2,353 23,387 (6,816)
Depreciation and amortization 34,868 33,160 27,100
Other non-cash expense, net 30,623 35,104 27,660
Stock-based compensation expense 12,627 22,008 17,181
Gain on derivative instruments, net (7,816) 0 0
Deferred income taxes (52,905) (16,665) (48,078)
Excess tax benefit from stock-based payment arrangements 0 (1,724) (11,928)
Provision for (reversal of) allowances on receivable portfolios, net 84,177 (6,763) (17,407)
Changes in operating assets and liabilities      
Deferred court costs and other assets (20,364) (33,430) (11,282)
Prepaid income tax and income taxes payable 25,417 (29,504) 22,180
Accounts payable, accrued liabilities and other liabilities 2,439 43,135 9,832
Net cash provided by operating activities 128,236 116,092 106,720
Net cash provided by (used in) operating activities from discontinued operations 2,096 (1,667) 4,824
Net cash provided by operating activities 130,332 114,425 111,544
Investing activities:      
Cash paid for acquisitions, net of cash acquired (675) (276,575) (446,165)
Proceeds from divestiture of business, net of cash divested 106,041 0 0
Payments to Acquire Assets Held-for-Sale (19,874) 0 0
Purchases of receivable portfolios, net of put-backs (907,413) (749,760) (862,997)
Collections applied to investment in receivable portfolios, net 659,321 635,899 633,960
Purchases of property and equipment (31,668) (28,624) (23,084)
Proceeds from derivative instruments, net 8,800 0 0
Other, net 1,994 (1,233) (5,102)
Net cash used in investing activities (183,474) (420,293) (703,388)
Net cash provided by (used in) used in investing activities from discontinued operations 14,685 (52,416) (51,809)
Net cash used in investing activities (168,789) (472,709) (755,197)
Financing activities:      
Payment of loan costs (32,338) (17,995) (20,101)
Proceeds from credit facilities 586,016 1,084,393 1,343,417
Repayment of credit facilities (615,857) (898,086) (1,184,244)
Proceeds from senior secured notes 442,610 332,693 288,645
Repayment of senior secured notes (352,549) (15,000) (15,000)
Proceeds from issuance of convertible senior notes 0 0 161,000
Proceeds from issuance of securitized notes 0 0 134,000
Repayment of securitized notes (935) (44,251) (29,753)
Purchases of convertible hedge instruments 0 0 (33,576)
Repurchase of common stock 0 (33,185) (16,815)
Taxes paid related to net share settlement of equity awards (4,829) (6,289) (20,324)
Excess tax benefit from stock-based payment arrangements 0 1,724 11,928
Proceeds from other debt 36,172 0 0
Other, net (15,037) (2,159) 7,146
Net cash provided by financing activities 43,253 401,845 626,323
Net increase (decrease) in cash and cash equivalents 4,796 43,561 (17,330)
Effect of exchange rate changes on cash and cash equivalents (8,624) (14,131) 15,280
Cash and cash equivalents, beginning of period 153,593 124,163 126,213
Cash and cash equivalents, end of period 149,765 153,593 124,163
Cash and cash equivalents of discontinued operations, end of period 0 29,600 32,644
Cash and cash equivalents of continuing operations, end of period 149,765 123,993 91,519
Supplemental disclosures of cash flow information:      
Cash paid for interest 147,899 151,946 95,034
Cash paid for income taxes, net 60,071 84,101 69,948
Supplemental schedule of non-cash investing and financing activities:      
Fixed assets acquired through capital lease $ 55 $ 2,220 $ 8,341